Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Active, not recruiting
A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males
NCT06465914· Phase 3· Shanghai Bovax Biotechnology Co., Ltd.· Source
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error